Literature DB >> 7531975

Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels: possible mediation via protein kinase C.

K Sharma1, T M Danoff, A DePiero, F N Ziyadeh.   

Abstract

Increased blood flow and vascular permeability of early diabetes have been associated with increased nitric oxide formation in diabetic rats, but the specific nitric oxide synthase responsible is unknown. We examined the modulation of the induction and activity of the inducible NOS isoform by high glucose concentration in a murine macrophage cell line, RAW 264.7, and murine glomerular mesangial cells. Culturing both cell types in high glucose concentration led to significant increases in nitrite production and the mRNA encoding iNOS upon stimulation with LPS plus interferon-gamma, as compared with normal glucose concentration. High glucose also modestly enhanced LPS/IFN-gamma-induced stimulation of the iNOS promoter in transient transfection experiments in mesangial cells. Protein kinase C activation led to enhanced mRNA expression of iNOS, and inhibitors of protein kinase C blocked nitrite accumulation in mesangial cells. These findings suggest that high glucose in combination with stimulation by LPS plus IFN-gamma enhances iNOS expression, and protein kinase C activation may be playing a role in this enhancement.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7531975     DOI: 10.1006/bbrc.1995.1156

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  High glucose increases nitric oxide generation in lipopolysaccharide-activated macrophages by enhancing activity of protein kinase C-α/δ and NF-κB.

Authors:  Kuo-Feng Hua; Szu-Hsuan Wang; Wei-Chih Dong; Chai-Yi Lin; Chen-Lung Ho; Tzu-Hua Wu
Journal:  Inflamm Res       Date:  2012-06-16       Impact factor: 4.575

2.  Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes.

Authors:  I Vareniuk; I A Pavlov; I G Obrosova
Journal:  Diabetologia       Date:  2008-09-19       Impact factor: 10.122

Review 3.  Molecular insights and therapeutic targets for diabetic endothelial dysfunction.

Authors:  Jian Xu; Ming-Hui Zou
Journal:  Circulation       Date:  2009-09-29       Impact factor: 29.690

4.  The involvement of protein kinase C in nitric oxide-induced damage to rat isolated colonic mucosal cells.

Authors:  B L Tepperman; Q Chang; B D Soper
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

Review 5.  Pathogenic role of nitric oxide alterations in diabetic nephropathy.

Authors:  Sharma S Prabhakar
Journal:  Curr Diab Rep       Date:  2005-12       Impact factor: 4.810

6.  Nicotinic receptor mediates nitric oxide synthase expression in the rat gastric myenteric plexus.

Authors:  K Nakamura; T Takahashi; M Taniuchi; C X Hsu; C Owyang
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

7.  NADPH diaphorase activity in the rat retina during the early stages of experimental diabetes.

Authors:  Qing Li; Esther Zemel; Benjamin Miller; Ido Perlman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-09-02       Impact factor: 3.117

8.  PP2B-dependent NO production in the medullary thick ascending limb during diabetes.

Authors:  Jan M Foster; Pamela K Carmines; Jennifer S Pollock
Journal:  Am J Physiol Renal Physiol       Date:  2009-05-20

9.  Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB.

Authors:  Zhiyuan Yu; Wenzheng Zhang; Bruce C Kone
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

10.  Mice deficient in PKCbeta and apolipoprotein E display decreased atherosclerosis.

Authors:  Evis Harja; Jong Sun Chang; Yan Lu; Michael Leitges; Yu Shan Zou; Ann Marie Schmidt; Shi-Fang Yan
Journal:  FASEB J       Date:  2008-11-26       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.